source
- China proposes ban on biotech platform sales but keeps licensing deals openChinese ministries of Commerce and Science and Technology released a draft policy that would prohibit the transfer of ownership for five biotech technologies, including cell and gene therapy, small…
- Enlivex cuts 60% of staff, halts preclinical R&D and slashes exec salaries to fund osteoarthritis trialEnlivex, an Israeli biotech developing a cell‑based immunotherapy called allocetra for knee osteoarthritis, announced today that it is reducing its workforce by 60 percent. The cut reduces the sta…